NBIO - NBIO Fits Profile for Strategy Targeting Early Stage Biotech January, 18 2023 07:06 AM Nascent Biotech Markets are starting to perk up in 2023 after a long and difficult bear market year in 2022. Investors eager to put capital back to […] For further details see: NBIO Fits Profile for Strategy Targeting Early Stage Biotech